Michael Scolaro

Michael Scolaro

Sep 08, 2017

Group 6 Copy 170
-1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can we make anesthesia for dogs safer with the help of nutrition?

Hypothermia, low body temperature, is one of the most common complications of anesthesia and can result...

Decreasing the Risk of Death and Diving Injuries in Artisanal Fishermen

Artisanal fishermen risk their lives every day to support their families and communities. Using outdated...

Developing a New Mouse Model for Studying Chemotherapeutic Nephrotoxicity

A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to...

Backer Badge Funded